EUVIMEDEUVIMED entdecken
Open Access

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States

Gabriel S Tajeu iD, Natalia Ruiz-Negrón, Andrew E Moran iD, Zugui Zhang, Paul Kolm iD, William S Weintraub iD, Adam P Bress iD, Brandon K Bellows iD

Circulation: Cardiovascular Quality and Outcomes · 2024-03 · 17 (3)

DOI: 10.1161/circoutcomes.123.009999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2024-03. Verfasst von Gabriel S Tajeu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Administration and Policy, Temple University, Philadelphia, PA (G.S.T.). Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Failure. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiovascular disease (CVD) is among the costliest conditions in the United States, and cost-effectiveness analyses can be used to assess economic impact and prioritize CVD treatments. We aimed to develop standardized, nationally representative CVD events and selected possible CVD treatment–related complication hospitalization costs for use in cost-effectiveness analyses. METHODS: Nationally representative costs were derived using publicly available inpatient hospital discharge data from the 2012-2018 National Inpatient Sample. Events were identified using the principal International Classification of Diseases , Ninth Revision and International Classification of Diseases , Tenth Revision codes. Facility charges were converted to costs using charge-to-cost ratios, and total costs were estimated by applying a published professional fee ratio. All costs are reported in 2021 US dollars. Mean costs were estimated for events overall and stratified by age, sex, and survival status at discharge. Annual costs to the US health care system were estimated by multiplying the mean annual number of events by the mean total cost per discharge. RESULTS: The annual mean number of hospital discharges among CVD events was the highest for heart failure (1 087 000 per year) and cerebrovascular disease (800 600 per year). The mean cost per hospital discharge was the highest for peripheral vascular disease ($33 700 [95% CI, $33 300–$34 000]) and ventricular tachycardia/ventricular fibrillation ($32 500 [95% CI, $32 100–$32 900]). Hospitalizations contributing the most to annual US health care costs were heart failure ($19 500 [95% CI, $19 300–$19 800] million) and acute myocardial infarction ($18 300, [95% CI, $18 200–$18 500] million). Acute kidney injury was the most frequent possible treatment complication (515 000 per year), and bradycardia had the highest mean hospitalization costs ($17 400 [95% CI, $17 200–$17 500]). CONCLUSIONS: The hospitalization cost estimates and statistical code reported in the current study have the potential to increase transparency and comparability of cost-effectiveness analyses for CVD in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHeart FailureHumansUnited StatesHospitalizationHealth Care CostsPatient Discharge

Stichwörter der Autor:innen

cardiovascular diseasesheart failurehospitalizationmyocardial infarctionstroke

Autor:innen und Institutionen

  • Department of Health Services Administration and Policy, Temple University, Philadelphia, PA (G.S.T.).
  • College of Pharmacy (N.R.-N.), The University of Utah, Salt Lake City.
  • Division of General Medicine, Columbia University Irving Medical Center, New York, NY (A.E.M., B.K.B.).
  • Christiana Care Health System, Newark, DE (Z.Z.).
  • MedStar Health Research Institute and Department of Medicine, Georgetown University, Washington, DC (P.K., W.S.W.).
  • Department of Population Health Sciences (A.P.B.), The University of Utah, Salt Lake City.

ORCID-Profile: Gabriel S Tajeu, Andrew E Moran, Paul Kolm, William S Weintraub, Adam P Bress, Brandon K Bellows

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Tajeu, G. S., Ruiz-Negrón, N., Moran, A. E., Zhang, Z., Kolm, P., Weintraub, W. S., Bress, A. P., & Bellows, B. K. (2024). Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States. Circulation: Cardiovascular Quality and Outcomes, 17(3). https://doi.org/10.1161/circoutcomes.123.009999

Vancouver

Tajeu GS, Ruiz-Negrón N, Moran AE, Zhang Z, Kolm P, Weintraub WS, et al. Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States. Circulation: Cardiovascular Quality and Outcomes. 2024;17(3). doi:10.1161/circoutcomes.123.009999

BibTeX
@article{Tajeu2024,
  author = {Tajeu, Gabriel S and Ruiz-Negrón, Natalia and Moran, Andrew E and Zhang, Zugui and Kolm, Paul and Weintraub, William S and Bress, Adam P and Bellows, Brandon K},
  title = {Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States},
  journal = {Circulation: Cardiovascular Quality and Outcomes},
  year = {2024},
  volume = {17},
  number = {3},
  doi = {10.1161/circoutcomes.123.009999}
}
Kostenlos starten →